Skip to content

Aetion has entered into an agreement to be acquired by Datavant, a leading health data platform company.   Learn more → 

GettyImages-2190510424 (2)-1

Data partnerships driving scalable decision-making

Aetion partners with a curated network of high-quality data providers to ensure access to fit-for-purpose data for decision-grade evidence.
GettyImages-1296232886-1

A global partner in shaping decision-grade evidence

Through strategic partnerships with leading data providers, Aetion delivers decision-grade evidence across a broad spectrum of therapeutic areas, study designs, and real-world applications.

Benefits

Aetion offers generous benefits to its full-time employees, which currently can include:

benefit-1
Array of options for Medical, Dental, and Vision Insurance
benefit-2
Free membership to OneMedical
benefit-3
Flexible Spending Accounts for Healthcare and Dependent Care
benefit-4
Commuter Benefits for Parking and Transit
benefit-5
4% 401(k) match on Retirement Savings Plan
benefit-7
Unlimited paid time off
benefit-8
16 weeks of paid parental leave
benefit-9
One month paid sabbatical after five years at Aetion
benefit-11
Stipend towards wellness related expenses like gym memberships, fitness classes, and more
benefit-12
Company activities including happy hours, annual rally, summer social, lunch ‘n learns, and more!

The benefits offering may differ based on geographies where employees are based, when outside of the United States.

Explore data provider partnerships

Claims, EHRs, and patient registries

These datasets provide broad-scale insights into treatment patterns, safety monitoring, and real-world effectiveness. Regulators and payers rely on these sources for post-market safety studies, reimbursement decisions, and health economics evaluations. 

Aetion works with leading data providers such as Optum, HealthVerity, IBM MarketScan, and BHI to ensure high-quality, structured claims and EHR data for regulatory applications.

GettyImages-1483243079 (1) (1)

Genomics and precision medicine data

As regulatory bodies shift toward biomarker-driven approvals and personalized treatment strategies, genomic and precision medicine data is critical for rare disease research, label expansions, and advanced clinical trial designs.

Our partnerships with Guardant Health, Tempus, Invitae, and Flatiron enable us to generate fit-for-purpose, regulatory-aligned real-world evidence (RWE) in oncology, rare diseases, and targeted therapies. 

GettyImages-2164594451 (2)

Therapeutic area-specific datasets

Aetion partners with leading providers of disease-contextualized data to deliver insights for RWE generation. 

For oncology, hematology, and rare diseases, datasets from ConcertAI, COTA, and Treat-NMD allow us to deliver disease-specific insights for regulatory filings, HEOR, and payer engagement.

GettyImages-2163194541 (2)

Experts in providing real-world evidence solutions

Connect with us to work with the team advancing critical decisions in healthcare.

THE LATEST FROM AETION

Explore new perspectives on the Aetion Evidence Hub

Uncover timely insights and emerging trends in real-world data and evidence from our A-Team of experts.